ARCHIVES

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

This article is from The Cancer Letter archive.

Vol. 28 No. 32 | September 6, 2002

Download PDF Visit The Full Archive

Related Articles

Louis Sullivan Blasts Tobacco, Sports Links

May 10, 1991

ASCO Highlights Seven of 4,000 Abstracts Submitted for Annual Meeting, June 3-7

May 27, 2011

New NCI Director Proposes $9 Million Community Cancer Centers Program.

September 8, 2006

Gene Expression Analyses Can Guide MDS Treatments

December 30, 2011

New Mexico, Missouri, Columbia Next for Review As comprehensive Centers; UCLA Decision In October

September 17, 1976

Gallo Breakthrough On AIDS Etiology To Be Reported Soon

April 20, 1984